share_log

Wells Fargo Maintains Overweight on Ionis Pharmaceuticals, Lowers Price Target to $82

Wells Fargo Maintains Overweight on Ionis Pharmaceuticals, Lowers Price Target to $82

富国银行维持对爱奥尼斯制药的增持,将目标股价下调至82美元
Benzinga ·  05/08 10:43

Wells Fargo analyst Yanan Zhu maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Overweight and lowers the price target from $85 to $82.

富国银行分析师朱亚南维持爱奥尼斯制药公司(纳斯达克股票代码:IONS)的增持,并将目标股价从85美元下调至82美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发